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DNA double-strand breaks (DSBs) in B lymphocytes
arise stochastically during replication or as a result of
targeted DNA damage by activation-induced cyti-
dine deaminase (AID). Here we identify recurrent,
early replicating, and AID-independent DNA lesions,
termed early replication fragile sites (ERFSs), by
genome-wide localization of DNA repair proteins
in B cells subjected to replication stress. ERFSs
colocalize with highly expressed gene clusters and
are enriched for repetitive elements and CpG
dinucleotides. Although distinct from late-replicating
common fragile sites (CFS), the stability of ERFSs
and CFSs is similarly dependent on the replication-
stress response kinase ATR. ERFSs break spon-
taneously during replication, but their fragility is
increased by hydroxyurea, ATR inhibition, or deregu-
lated c-Myc expression. Moreover, greater than
50% of recurrent amplifications/deletions in human
diffuse large B cell lymphoma map to ERFSs. In
summary, we have identified a source of sponta-
neous DNA lesions that drives instability at preferred
genomic sites.INTRODUCTION
Double-strand breaks (DSBs) arise spontaneously during DNA
replication, as a result of oncogenic stress, and as a part of the
gene diversification programs in lymphocytes (Bartek et al.,620 Cell 152, 620–632, January 31, 2013 ª2013 Elsevier Inc.2007; Calle´n et al., 2007; Gostissa et al., 2011; Halazonetis
et al., 2008). When B lymphocytes are activated, they undergo
rapid proliferation and simultaneously initiate two-genome re-
modeling reactions, termed somatic hypermutation (SHM) and
class switch recombination (CSR). The coupling of rapid cycling
and programmed DNA damage poses the B cell genome at high
risk for destabilization.
SHM introduces point mutations in the variable region of
immunoglobulin (Ig) genes, which can increase antibody affinity,
whereas CSR is a DNA deletion event that replaces one Ig
constant region gene for another. Both of these reactions are
initiated by the enzyme activation-induced cytidine deaminase
(AID), which deaminates cytosine residues in single-stranded
DNA exposed during Ig gene transcription (Chaudhuri and Alt,
2004). In addition to Ig genes, AID causes a considerable amount
of collateral genomic damage (Chiarle et al., 2011; Kato et al.,
2012; Klein et al., 2011; Liu et al., 2008), including oncogenic
targets such as c-Myc (Robbiani et al., 2008). Nevertheless,
many recurrent mutations in B cell lymphoma are not associated
with AID activity, and the mechanisms of rearrangements at
these sites remain unclear.
The DNA damage response (DDR) is activated during pro-
grammed rearrangements in lymphocytes to ensure faithful
DNA repair and prevent chromosomal translocation (Chen
et al., 2000; Petersen et al., 2001). The DDR is also triggered
by aberrant oncogene expression that induces precocious entry
into S phase and perturbs replication fork progression (Bartek
et al., 2007; Bester et al., 2011; Halazonetis et al., 2008). Replica-
tion fork instability can also be triggered by exogenous agents
such as hydroxyurea (HU), which depletes deoxynucleotide
pools, or by deficiencies in homologous recombination path-
ways that are needed to complete DNA replication after fork
stalling or collapse (Schlacher et al., 2012).
Oncogenic stress has been shown to preferentially target
genomic regions called common fragile sites (CFSs) (Bartek
et al., 2007; Halazonetis et al., 2008). Historically, CFSs have
been mapped in lymphocytes but are induced in all cell types
under conditions that obstruct replication, such as treatment
with low doses of the DNA polymerase inhibitor aphidicolin.
DNA breakage within CFSs spans megabase regions. Neverthe-
less, CFSs share characteristic features including association
with very large genes, enrichment of long stretches of AT dinu-
cleotide-rich repeats, and incomplete DNA replication (Durkin
and Glover, 2007).
Replication-stress-induced DNA damage is also observed in
yeast. Similar to CFSs, sites located in ‘‘replication slow zones’’
(RSZs) are late replicating and breakage prone (Cha and Kleck-
ner, 2002). In addition to late replicating areas, irreversible repli-
cation fork collapse in response to acute doses of hydroxyurea
has been observed preferentially around a subset of early firing
replication origins in yeast (Raveendranathan et al., 2006), which
do not overlap with RSZs (Cha and Kleckner, 2002; Hashash
et al., 2011). Although the molecular mechanisms governing
replication initiation in yeast and mammalian cells are distinct,
we wondered if fragility at early firing origins is also a feature of
mammalian cells. Here, we identify highly unstable regions of
the B cell genome designated as ‘‘early replicating fragile sites’’
(ERFSs). We propose that ERFSs are a new class of fragile sites
in mammalian cells that contribute to recurrent rearrangements
during lymphomagenesis.
RESULTS
Genome-wide Mapping of Replication-Induced DNA
Damage
Single-strand DNA (ssDNA) mapping has been used to localize
origins of replication in yeast (Feng et al., 2006). To identify
potential sites of fork collapse, we first profiled the location
and extent of ssDNA genome-wide using chromatin immunopre-
cipitation (ChIP) with an anti-replication protein A (RPA) antibody
(Figure 1). RPA associates with ssDNA at stalled forks near early
firing origins when fork movement is inhibited by HU (Tanaka and
Nasmyth, 1998).
Freshly isolated mouse B cells are arrested in the G0 phase of
the cell cycle (Figure 1A). Upon stimulation with LPS/IL4, cells
synchronously enter into the cell cycle so that by 22 hr, approx-
imately 8% of cells have entered S phase, whereas at 28 hr over
30% are in S/G2 phases (Figure 1A). To profile early replication
origins, we treated cells at 22 hr with 10 mM HU for 6 hr to fully
arrest cells at G1/S (Figures 1A and 1B). We then performed
ChIP-seq of RPA in both untreated and HU-treated cells at
28 hr (Figures 1A and 1B). Two independent experiments
showed reproducibility of genome-wide RPA association in
HU-treated cells (Figure S1A available online). We generated
profiles of RPA in untreated and treated samples, centered on
individual RPA-bound sites (Figure S1B), and observed amarked
increase in the intensity of RPA in HU-treated B cells relative to
untreated cells where 5,939 out of 11,942 genomic regions
(49.7%) displayed more than a 4-fold increase in RPA recruit-
ment. In addition to the 53% overlap of RPA-associated regions
between HU-untreated versus -treated cells, we also observedthat 1,441 regions were present only in HU-treated samples (Fig-
ure S1B). These HU-dependent ssDNA regions may correspond
to the firing of new replication origins to compensate for ineffi-
cient replication.
To confirm that RPA recruitment maps early replication zones,
we used the Repli-Seq approach (Hansen et al., 2010) to identify
replication origins in B cells during HU arrest. Approximately
12,000 early activating replication origins across the murine B
cell genomewere identified (FigureS1C).Bycomparing thedistri-
bution of BrdU incorporation relative to the individual RPA-occu-
pied genomic regions,we observed association of BrdU incorpo-
ration with nearly 80% of RPA-bound regions (Figure S1C).
Moreover, more than 86% of RPA/BrdU enriched genomic sites
coincided with previously mapped early replicating regions in
the mouse B cell line CH12 (Stamatoyannopoulos et al., 2012)
(p(permutation) < 1 3 105, Figure S1D). Thus, HU-arrested B
cells exhibited an enrichment of RPA at early replicating zones,
consistent with an early S phase cell-cycle arrest (Figure 1A).
Early replicating regions are associated with accessible chro-
matin configuration (MacAlpine et al., 2004). In agreement with
this, we found that more than 67% of RPA-bound regions in
HU-arrested cells reside within intragenic sequences (Figures
S1E and S1I), a frequency significantly higher than expected
(p(permutation) < 1 3 105). Moreover, RPA preferentially asso-
ciated with DNaseI hypersensitive sites (DHS) and euchromatic
promoters marked by H3K4me3 (Figure S1F). Finally, we
measured transcriptional activity in HU-treated B cells directly
by genome-wide RNA sequencing. We observed high transcrip-
tion activity within the RPA-occupied genomic regions as shown
by the aggregated pattern of RNA-Seq centered on those
regions (Figure S1G). Moreover, 6,100 RPA-bound RefSeq
genes exhibited significantly higher average mRNA abundance
than those that did not show RPA binding (p < 1 3 1016, Fig-
ure S1H). Thus, HU-induced RPA recruitment in early S phase
maps to actively transcribed genes that show the hallmarks of
euchromatin.
Replisome stalling in response to HU triggers the activation of
the ATR kinase (Ward and Chen, 2001), which protects forks
from collapse (Cimprich and Cortez, 2008), and leads to phos-
phorylation of H2AX (g-H2AX) (Ward and Chen, 2001), which
colocalizes with RPA (Petermann et al., 2010). To examine the
relative distribution of g-H2AX and RPA genome-wide, we
carried out ChIP-seq with an antibody that recognizes g-H2AX
(Figure S1A) and examined their profiles with respect to the
center of RPA-bound sites. g-H2AX-associated genomic
regionsweremuch broader than RPA, but these regions overlap-
ped with 93% of RPA-bound sites marking ssDNA in HU-treated
cells (Figure 1C), consistent with the finding that g-H2AX marks
stalled forks even prior to DSB formation (Petermann et al.,
2010). g-H2AX/RPA enriched loci may therefore correspond to
a combination of stalled and broken replisomes.
Cells deficient in homologous recombination (HR) pathway
components, such as XRCC2, often accumulate spontaneous
chromosome breaks and exhibit hypersensitivity to HU (Sonoda
et al., 1998). Consistent with increased spontaneous DNA
damage at replication forks, untreated XRCC2/ cells exhibited
accumulation of g-H2AX at similar genomic regions and at
almost similar levels observed in HU-treated wild-type (WT)Cell 152, 620–632, January 31, 2013 ª2013 Elsevier Inc. 621
G0 G1/S
stimulate 
22h grow
6h
G1/S arrest
+HU
G1/S/G2+0
B
SMC5 (10 mM HU)
BRCA1 (10 mM HU)
RPA (10 mM HU)
5611
2538
2829
2498
1298
276
2204
E
S/G2
6.24%
28h, 10mM HU
DNA content
F
0.0
0.5
1.0
1.5
DN
A T
ran
spo
son
LIN
E(L
1)
LIN
E(L
2) LTR SIN
E
tRN
A/r
RN
A/s
nR
NA
 sc
RN
A/s
rpR
NA
Sim
ple
 Re
pea
t
re
la
tiv
e 
fre
qu
en
cy
G
D
4022
RPA SMC5 BRCA1
10 mM HU
0
>20
C RPA γ-H2AX
0
>400
H
10 mM HU
20kb
S/G2
30.7%
28h, 0mM HU
DNA content
S/G2
7.9%
22h, 0 mM HU
DNA content
S/G2
0.42%
0h, 0mM HU
DNA content
ce
ll 
co
un
t
20kb 20kb200kb 2Mb
centered on RPA-bound regions centered on RPA-bound regions
I
*
* * *
R
P
A
-b
ou
nd
 re
gi
on
s
R
P
A
-b
ou
nd
 re
gi
on
s
1.0
1.5
2.0
2.5
3.0
3.5
4.0
20 0 20
distance from ERFS center (kb)
150
200
250
300
350
400
to
ta
l C
pG
 is
la
nd
 s
eq
ue
nc
es
 (k
b)
ERFS
tra
ns
cr
ip
t p
ai
r (
co
un
t)
20
40
60
80
100
120
ERFS ERFS
convergent divergent
no
rm
al
iz
ed
 re
ad
 c
ou
nt
A
Figure 1. Mapping Replication-Induced DNA Damage in Murine B Lymphocytes
(A) FACS analysis showing DNA content of freshly isolated and ex vivo stimulated splenic murine B lymphocytes in the absence and presence of 10 mM HU.
(B) Experimental plan describing cell synchronization and isolation for samples used in ChIP-seq and RNA-Seq experiments.
(legend continued on next page)
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B cells (Figures S2A–S2C). 90% of g-H2AX-associated genomic
regions in untreated XRCC2/ cells correlate with the regions
enriched for this protein in HU-treated WT B cells (Figure S2B),
and nearly 80% of the regions with enriched g-H2AX observed
in HU-treated WT B cells overlapped with those seen in HU-
treated XRCC2/ cells (Figure S2C). These data indicate that
XRCC2 deficiency leads to increased endogenous levels of
replication stress mostly at the same loci where HU induces
replication fork stalling and/or breakage in WT cells.
RPA, BRCA1, and SMC5 Colocalization Marks the Sites
of Replication Stress in Early Replicating Zones
Like XRCC2, BRCA1 and members of the structural mainte-
nance of chromosome (SMC) family have been implicated
in promoting replication fork restart (Schlacher et al., 2012;
Stephan et al., 2011). To determine whether HR proteins bind
to a subset of stalled forks marked by RPA and g-H2AX, we
also defined the genome-wide profile of BRCA1 and SMC5.
We confirmed BRCA1 and SMC5 ChIP-seq efficacy by
observing their association at both Sm and Sg1 in 53BP1/
cells, where the breaks in IgH persist unrepaired and undergo
extensive resection (Figure S3A) (Bothmer et al., 2010; Bunting
et al., 2010, 2012; Yamane et al., 2011, 2013).
We then determined the localization of BRCA1 and SMC5 in
HU-arrested B cells. Two independent experiments showed
reproducibility of genome-wide BRCA1 and SMC5 association
(Figures S3B and S3C). To identify the RPA genomic sites co-
occupied by the HR proteins BRCA1 and SMC5, we plotted
the distribution of their binding with respect to the center of
individual RPA-bound regions. Overall, 2,204 regions spanning
10 kbp on average showed RPA/BRCA1/SMC5 triple colocaliza-
tion (Figures 1D and 1E). We found that RPA was recruited to
more than 88% of genomic sites exhibiting BRCA1 and SMC5
association (Figure 1E). Furthermore, genome-wide analysis of
RPA/BRCA1/SMC5 profiles in untreated cells revealed more
than a 21% increase in the number of genomic regions occupied
by these three proteins after HU treatment (Figure S4A). Never-
theless, 48% of RPA/BRCA1/SMC5 triple colocalizations were(C) For each RPA-bound site in response to 10mMHU (y axis), each column depic
RPA-bound sites. Colormap corresponds to binding intensitieswhere ‘‘black’’ rep
bound sites.
(D) RPA, SMC5, and BRCA1 co-occupy 2,204 genomic regions in response to 1
RPA, SMC5, and BRCA1 genomic occupancy in response to HU centered on RPA
sites.
(E) The Venn diagram shows the overlap of sites bound by RPA, SMC5, and BRC
each shared and unique area.
(F) Relative frequency of ERFSs in classes of repetitive sequences is shown. Da
(*, enriched repetitive element classes; p < 1 3 103).
(G) ERFSs are enriched in CpG islands. Total CpG island sequences in all the 2,20
model as indicated by the gray points. Each gray point corresponds to the total C
plot depicts the quantiles of total CpG sequences based on the permutation mo
(H) ERFS genomic regions are transcriptionally active. The line plot represents th
center of the ERFSs.
(I) ERFSs are enriched in transcriptionally active convergent and divergent gen
indicated by the crossed red point is compared to the permutation model as ind
divergent/convergent gene pairs observed in an iteration of the permutation mode
pair count based on the permutation model (p < 13 105). For definition of conve
S3, S4.common between the unperturbed and HU-arrested B cells
(Figure S4A). Therefore, we hypothesized that chromatin
with concomitant RPA, BRCA1, and SMC5 binding might corre-
spond to regions undergoing replication fork collapse both in
response to replication stress and during normal DNA replica-
tion. Given that our analysis focused on early replicating sites,
which contrasts with late replicating CFSs, we designated these
regions as ERFSs.
We then characterized ERFSs to determine whether they
share common underlying primary sequence characteristics.
Indeed, these loci were enriched at known repetitive elements,
including LINE L2, SINE, DNA transposons, and tRNA elements
(p(permutation) < 13 103, Figure 1F), which are known replica-
tion fork barriers (Mirkin and Mirkin, 2007). Furthermore, ERFSs
showed significantly higher G and C nucleotide content
compared to the whole mouse genome, in contrast to CFSs
that are enriched in A+T sequences (p(Wilcoxon) < 1 3 1016,
Figure S4B). Twenty-six percent of the ERFSs regions overlap-
ped with CpG islands, which are highly enriched at translocation
breakpoints in B cell lymphoma (Tsai et al., 2008). Conversely,
CpG islands covered approximately 400,000 nucleotides
within these regions (p(permutation) < 1 3 105, Figure 1G). As
anticipated, ERFSs clustered at early replication origins (Fig-
ure S4C), and over 66% of the loci overlapped with intragenic
or promoter sequences of RefSeq annotated protein coding
genes (p(permutation) < 1 3 103, Figures S4D and S4E).
Moreover, ERFSs are more transcriptionally active relative to
flanking genomic regions shown by relative mRNA enrichment
by RNA-Seq (Figure 1H). Indeed, more than 86% of the RefSeq
annotated genes with ERFSs are among the highest transcribed
genes (p(binomial) < 13 1016, Figure S4F). Finally, ERFSs were
significantly enriched in gene pairs that are transcribed in
converging or diverging directions (see Experimental Proce-
dures), such as the convergent transcription pair of IKZF1 and
FIGNL1 shown in Figure 2A. Compared to expected values,
ERFSs were at least two times more likely to localize in regions
containing gene pairs exhibiting convergent and/or divergent
gene pairs (p(permutation) < 1 3 105, Figure 1I).ts the presence of RPA (left) and g-H2AX (right) within a window centered on the
resents no binding. K-mean clustering algorithmwas used to group the protein-
0 mM HU. The plot in each column, from left to right, represents the pattern of
-bound sites. K-mean clustering algorithm is used to group the protein-bound
A1 in response to 10 mM HU. The total number of bound sites is indicated for
shed line indicates the expected frequency based on the permutation model
4 ERFSs as indicated by the crossed red point is compared to the permutation
pG island sequences covered in an iteration of the permutation model. The box
del (p < 1 3 105).
e average RNA tag count (loess smoothed) in a genomic window around the
e pairs. Count of divergent/convergent gene pairs coinciding with ERFSs as
icated by the gray points. Each gray point corresponds to the total number of
l. The box plot depicts the quantiles of the total convergent/divergent transcript
rgent/divergent gene pairs see Experimental Procedures. See also Figures S1,
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Figure 2. ERFS ‘‘Hot Spots’’ Associate with
Highly Transcribed Gene Clusters
(A) Gene tracks represent, from the top, ERFS and
ERFS hot spot demarcations; bindings of RPA,
BRCA1, SMC5, gH2AX occupancy; and BrdU
incorporation near the IKZF1 locus. The y axis
represents the total number of mapped reads per
million of mapped reads (RPM) in 200 nucleotide
windows (sliding-window smoothed).
(B) Genome-wide map of 619 ERFS hot spots.
Each hot spot is represented by a green dot on the
ideograms. The top fifteen hot spots are color-
coded in red.
(C) Table of the top 15 ERFS hot spots. ERFS hot
spots are ordered based on a ranked statistics of
RPA/SMC5/BRCA1-binding strength (see Experi-
mental Procedures). The first column depicts
a representative gene within the hot spot. A hot
spot containing at least three genes is designated
as a ‘‘gene-cluster.’’ A hot spot with a gene tran-
script value greater than 1 RPKM (reads per kilo-
base exon model per million mapped reads) is
designated as transcribed. ERFS rearrangements
in B cell cancers are listed in Table S2. ERFS is
designated as ‘‘AID-target’’ according to (Chiarle
et al., 2011; Klein et al., 2011). For complete defi-
nition of columns see Experimental Procedures.
See also Tables S1 and S2.Replication is organized into discrete zones (30–450 kbp in
size) containing multiple replication origins that exhibit similar
replication timing (Costa and Blow, 2007). Similarly, approxi-
mately 80% of the ERFSs are within 300 kbp of one another
(Figures 2A and S4G). We therefore integrated these neighboring
clustered ERFSs and removed those with footprints less than
10 kbp to define 619 triple colocalized hot spot regions (Fig-
ure 2B; Table S1). Interestingly, whereas these hot spots were
distributed throughout the genome, the density of hot spots on
autosomes was higher than on the sex chromosomes, which624 Cell 152, 620–632, January 31, 2013 ª2013 Elsevier Inc.have a lower gene density (Figure 2B).
An examination of the top 15 hot spots
based on a ranked statistics of RPA/
BRCA1/SMC5-binding strength showed
that 9 out of the 15 regions contained
gene clusters with at least three genes,
and 12 out of 15 exhibited divergent/
convergent gene pairs (Figures 2A and
2C; Table S1). Of note, 8 out of 15 hot
spots are also rearranged in B cell
lymphomas (Figure 2C; Table S2), sug-
gesting a possible link among ERFSs,
genome rearrangements, and cancer
(see below).
Early S Phase Arrest by HU Induces
DNA Damage at ERFSs, but Not
at CFSs
DNA damage at CFSs is visualized by
conventional cytogenetic analysis ofmetaphase chromosomes (Durkin and Glover, 2007). To investi-
gate whether the ERFSs defined by RPA/ BRCA1/SMC5 binding
are prone to actual breakage, we again treated cells with 10 mM
HU, released them into fresh medium overnight, and examined
metaphase spreads. Chromatid breaks, chromosome breaks,
and rearrangements could be discerned in 20%–60% of WT
cells after HU treatment (Figure S2D). To determine whether
ERFSs are more sensitive to breakage under replication stress
than regions lacking RPA/BRCA1/SMC5 binding (i.e., cold
spots), we hybridized metaphases with bacterial artificial
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Figure 3. ERFS Break in Response to HU
(A) Upper: diagram of FISH probes. Lower:
representative DNA aberrations identified by FISH.
Blue is DAPI-stained DNA, green represents the
BAC probe (MHCII, GIMAP, SWAP70, BACH2,
IKZF1, or FOXP1) and red marks telomeric DNA.
(B) HU-induced aberrations were found at ERFSs
but not at ‘‘cold sites’’ (CNTNAP4, SLITRK6) or
CFSs (FRA8E1, FRA14A2). Quantitation of abnor-
malities from FISH analysis of untreated cells (blue
bars) or cells treated with 10 mM HU (red bars).
The percent aberrations specifically at the BAC
probes relative to the total damage is plotted.
(C) Abnormalities detected by FISH in untreated
(blue bars) and 10 mM HU-treated (red bars)
XRCC2/ cells.
(D) Upper: diagram of FISH probes. Lower:
representative metaphase showing a sponta-
neous break at the GIMAP locus in an XRCC2/
cell.
(E) Quantitation of abnormalities detected by FISH
in untreated (blue bars) and 0.2 mM aphidicolin-
treated (red bars) WT cells.
(F) Upper: diagram of FISH probes. Lower:
representative metaphases showing aphidicolin-
induced breaks at the FRA14A2 and FRA8E1 loci
in WT cells. See also Figure S2 and Table S3.chromosome (BAC) probes corresponding to six ERFS hot spots
(MHCII, GIMAP, SWAP70, BACH2, IKZF1, and FOXP1) (Figures
3A and 3B), two cold spots (CNTNAP4 and SLITRK6) and two
CFSs (FRA8E1 and FRA14A2). For each of the six ERFS hot
spots, a total of at least 40 chromosome aberrations were
counted (Table S3). Notably, all six ERFS hot spots displayed
chromosome aberrations in metaphases from HU-treated
samples (Figure 3B). In contrast, neither of the cold regions or
CFSs was broken under the same conditions (Figure 3B). Over-
all, 8%–15%of the total damage localized to individual ERFS hotCell 152, 620–632spots, representing a significant fraction
of the total damage (Figure 3B). DNA
lesions were observed on either the
centromeric or telomeric sides of ERFS-
specific hybridized BAC (Figure S2E),
suggesting that an ERFS represents
a large fragile genomic region.
Aberrations at ERFS hot spots were
also detected in XRCC2/ cells treated
with HU (Figure 3C). XRCC2/ cells are
more sensitive to HU than WT cells are,
as evidenced by the higher level of total
damage in these cells (Figure S2D).
Breaks at MHCII, GIMAP, SWAP70,
BACH2, IKZF1, and FOXP1 were found
in 5%–10% of HU-treated XRCC2/
cells compared with 1%–6% of WT cells
damaged in these regions (Table S3).
Nevertheless, the frequency of ERFS-
specific instability relative to the total
damage was similar in XRCC2/ and
WT cells (Figures 3B and 3C). Interestingly, breaks in the vicinity
of the GIMAP hot spot were detectable spontaneously in
XRCC2/ cells (Figures 3C and 3D; Table S3), which is consis-
tent with increased g-H2AX observed in unchallenged XRCC2
mutant cells (Figure S2A).
None of the eight CFSs defined in mouse (Helmrich et al.,
2006) were among our 619 ERFS hot spots (Table S1). Consis-
tent with this, DNA aberrations at two of the most expressed
CFSs in mouse lymphocytes, FRA14A2 and FRA8E1 (Helmrich
et al., 2006) were undetectable in HU-treated WT samples, January 31, 2013 ª2013 Elsevier Inc. 625
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Figure 4. ERFS Break in Response to ATR
Inhibition and High Transcription
(A) Quantitation of aberrations observed by FISH
in response to overnight exposure to 1 mM ATRi in
WT (blue bars) and XRCC2/ cells (red bars).
(B) Gene tracks represent, from the top, ERFS
demarcation and transcription measured by RNA-
Seq in T and B cells at the region flanking SWAP70
locus.
(C) Relative transcriptional activities ofGIMAP and
SWAP70 loci in B and T cells and their relation to
the ERFS fragility. GIMAP and SWAP70 hot spots
are shown in separate facets. The x axis shows the
cell lineage. The y axis upward depicts the
log10(RPKM) in B and T cells by dark and light
reds, respectively; the y axis downward depicts
the quantitation of aberrations observed by FISH
in response to overnight exposure to 1 mM ATRi in
B and T cells in dark and light blue, respectively.
(D) Relative SWAP70 mRNA abundance
(measured across exon 4) normalized to b-actin in
WT and SWAP70/ B cells (mean ± SD).
(E) Quantitation of aberrations in WT and
SWAP70/ cells at the GIMAP and SWAP70
regions in response to 10 mM HU. See also Fig-
ure S5 and Table S3.(Figure 3B). Absence of CFS expression could be explained by
the fact that high concentrations of HU stall replication forks in
early S phase (Figure 1A), whereas CFSs replicate late (Durkin
and Glover, 2007). Conversely, we found that overnight treat-
ment with low doses of aphidicolin (0.2 mM for 20 hr) induced
damage at the CFSs FRA14A2 and FRA8E1, whereas the ERFSs
GIMAP and SWAP70 were largely insensitive (Figures 3E and
3F). These data are consistent with the idea that ERFS arise
from fork collapse during early replication, whereas breakage
at CFSs arises from a failure to replicate (Debatisse et al.,
2012), and the two forms of replication stress induce distinct
types of recurrent DNA lesions.626 Cell 152, 620–632, January 31, 2013 ª2013 Elsevier Inc.ATR Inhibition Promotes ERFS
and CFS Expression
The ATR kinase protects the genome
from chromosomal aberrations at late
replicating CFSs, (Durkin and Glover,
2007) and is essential for stabilizing
stalled forks and facilitates fork restart in
early S phase (Cimprich and Cortez,
2008). To confirm that ATR inactivation
induces CFSs and determine whether it
similarly leads to damage at ERFSs, we
treated asynchronous B cells on day 2
with 1 mM of a recently described ATR
inhibitor (ATRi) (Toledo et al., 2011). We
found that approximately 2.5% and
7.0% of the total chromosomal aberra-
tions localized to the two CFSs, FRA8E1
and FRA14A2, respectively (Figure 4A).
ATR deficiency also led to chromosomal
aberrations at ERFSs at a similarfrequency (Figure 4A; Table S3). Moreover, ERFSs and CFSs
were both damaged in XRCC2/ cells treated with ATRi (Fig-
ure 4A). Thus, the rupture of unreplicated regions at CFSs and
fork collapse at ERFSs are similarly sensitive to ATR inhibition.
Transcriptional Activity Can Increase ERFS Fragility
As described above, ERFSs are enriched in regions with high
transcriptional activity (Figures 1H, 2C, and S4F; Table S1). To
determine the contribution of transcriptional activity to individual
ERFSs, we focused on loci with tissue-specific transcription
patterns. SWAP70 is a B-cell-specific developmental regulator,
whereas genes within the GIMAP cluster are expressed both in
B and in T cells (Figures 4B and S5A). Treatment with ATRi led to
a similar frequency of damage atGIMAP in B and T cells, consis-
tent with insignificant changes in gene expression between the
two cell types (Figure 4C). In contrast, damage near SWAP70
was 3-fold lower in T than in B cells (Figure 4C; Table S3), which
correlated with the decreased transcription of SWAP70 in T cells
(Figure 4B). Nevertheless, the replication timing near SWAP70
was similar in both cell types (Figure S5B). To further delineate
the role of transcription on ERFS breakage, we used
SWAP70/ mice in which 2.7 kbp, including the first exon and
part of the 50 untranslated region, is removed (Borggrefe et al.,
2001), allowing us to compare the fragility of ERFSs in the
same genomic region in knockout B cells. We determined that
SWAP70 mRNA in SWAP70/ B cells was reduced by approx-
imately 4-fold relative to levels in WT (Figure 4D). Moreover, DNA
damage near SWAP70 was approximately 2.5-fold lower in
SWAP70/ relative to levels in WT B cells (Figure 4E). In
contrast, DNA damage near GIMAP remained at a similar level
both in WT and SWAP70/ cells (Figure 4E). Although our
data indicate that high level of transcription contributes to the
breakage of some ERFSs, other molecular features, including
repetitive elements (Figure 1F), covalently bound protein
complexes, and RNA:DNA hybrids, might also be sources of
ERFS fragility.
Oncogenic Stress Can Trigger ERFS and CFS Fragility
Oncogene deregulation is thought to compromise genome
integrity preferentially at CFSs (Bartek et al., 2007; Halazonetis
et al., 2008), and CFS deletion has been associated with various
cancers (Bignell et al., 2010). To determine whether oncogenic
stress similarly induces DNA damage at ERFSs, we overex-
pressed c-myc in B cells because it has been implicated in regu-
lating replication initiation and origin firing (Dominguez-Sola
et al., 2007).XRCC2/ cells were utilized to increase the amount
of replicative stress and DNA damage as a result of decreased
HR (Figure S2D). c-myc overexpression led to induction of
p53 (Figure 5A), which correlated with an approximately 1.6-
fold increase in overall DNA damage in XRCC2/ cells overex-
pressing c-myc compared to empty vector (EV)-infected cells
(Table S3). Moreover, 7.3% of the total breaks generated in
c-myc overexpressing cells were found near SWAP70,
compared to 2.4% of total breaks at this ERFS in EV-infected
B cells (Figure 5B). Similarly, out of 43 breaks observed in
c-myc-infected cells, 3 (7%) were found at the GIMAP cluster,
and 3 (6.7%) were found near BACH2. c-myc overexpression
also induced breaks at FRA8E1, showing a 2-fold relative
increase in breaks relative to EV-infected cells (Figure 5B).
Thus, DNA damage induced by c-myc overexpression can occur
at ERFSs and CFSs.
ERFS Fragility Is AID Independent
Mutations and DSBs at various oncogenes, including c-myc, are
due to AID off-target activity (Robbiani et al., 2008). Recently,
a number of genome-wide studies in primary B cells mapped
AID-induced DNA translocation events, and identified several
novel hot spots for AID-dependent translocations at non-Ig
genes (Chiarle et al., 2011; Kato et al., 2012; Klein et al., 2011).
Among these translocation hot spots, MHCII, GIMAP, IKZF1,PVT1, ETS1, IRF4, and NFkB1 were located within the top 15
ERFS hot spots in this study, whereas the IgH locus (the physio-
logic target of AID) was not ranked high on the list (Figure 2C;
Table S1). To determine whether AID contributes to ERFS
fragility, we stimulated WT and AID knockout B cells with LPS/
IL4 for 2 days, and then treated them with ATRi overnight. These
conditions induce robust AID-dependent DNA damage simulta-
neously with replication stress. We probed metaphases with
BACs spanning the IgH locus, the GIMAP cluster, and IKZF1-
all AID translocation hot spots—as well as BACH2, SWAP70,
FOXP1, and BCL2 (Figure S2E)—ERFSs that are frequently rear-
ranged in B cell lymphoma (Figure 2C; Tables S1 and S2). In WT,
the IgH locus was damaged in 3.8% of cells, but the frequency of
IgH-specific instability did not increase with ATRi (Figure S2F),
despite the fact that ATRi greatly increased overall damage
(Table S3). Upon ATRi treatment, the frequency of breaks at
the ERFSs GIMAP, IKZF1, BACH2, SWAP70, and FOXP1, and
BCL2 were elevated to the levels similar to those observed at
the IgH in activated B cells (Figure S2F). Breaks at some ERFSs
were even spontaneously detected (FOXP1 and GIMAP,
Figure S2F).
To determine whether AID expression contributes to aberra-
tions observed at ERFSs, we next analyzed their breakage
frequency in AID/ cells. Unlike WT cells, IgH breaks were
absent in AID/ cells. In contrast, all ERFSs exhibited similar
levels of breakage both in WT and AID/ cells (Figure 5C; Table
S3). Therefore, whereas IgH breaks in B cells are entirely AID
dependent, the breakage of ERFSs is AID independent. Alto-
gether, these data suggest that some recurrent rearrangements
in B cell lymphoma are due to AID-independent replicative stress
at ERFSs.
Genome Instability at ERFSs Is Observed in Mouse
Models and Human Cancer
Among the top 15 ERFS hot spot that break in response to AID-
independent replication stress, we have identified three partners
that recurrently translocate to IgH in lymphomas: BACH2,
FOXP1, and BCL2 (Table S2). We hypothesized that if AID-
dependent DSBs in G1 persisted into early S phase, transloca-
tions between AID-dependent breaks and ERFS might be
detectable. To test this, we examined cells transgenically over-
expressing AID and simultaneously deficient for 53BP1
(IgkAID/53BP1/), thus allowing the persistence of G1 IgH
breaks into S phase where they could be joined to ERFSs.
Indeed, 26% and 7% of IgkAID/53BP1/ B cells carried IgH
locus andBACH2 breaks, respectively (Figure 5D). These breaks
are fusogenic because IgH- and BACH2-associated transloca-
tions to unidentified partner chromosomes were found in 7.3%
and 1.2% of the metaphases, respectively (Figure 5D). Impor-
tantly, we also detected one IgH/BACH2 translocation among
750 cells (Figure 5E), reminiscent of the IgH/BACH2 transloca-
tions observed in human B cell lymphoma (Kobayashi et al.,
2011). Thus, AID-dependent breaks generated in G1 (Petersen
et al., 2001) can join to ERFS breaks triggered in early S phase.
A hallmark of cancer genomes is widespread copy-number
changes, insertions, and deletions. To determine whether dele-
tions and/or amplifications at ERFSs are a general feature of
the B cell lymphoma genome, we compared our ERFSs withCell 152, 620–632, January 31, 2013 ª2013 Elsevier Inc. 627
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Figure 5. ERFS Fragility Is Observed in
Response to Oncogenic Stress and in
Human Cancer
(A) Western blot for phosphorylated p53 in c-myc
and EV-infected XRCC2/ B cells.
(B) Aberrations in c-myc-infected and EV-infected
XRCC2/ B cells.
(C) Aberrations in WT (blue bars) and AID/ B
cells (red bars) treated with 1 mM ATRi.
(D) Spontaneous chromosome breaks (blue bars)
and translocations (red bars) at the IgH and
BACH2 locus in IgkAID/53BP1/ B cells.
(E) Normal chromosomes and a translocation of
BACH2 ERFS (red) to the IgH locus (green) is
shown.
(F and G) ERFSs significantly overlap with MCRs
detected in DLBCL. The Venn diagram shows the
overlap of ERFSs with MCR found in DLBCL. The
total number of regions is indicated for each
shared and unique area and color-coded based on
the region’s title.
(G) Significance of correlation between the ERFSs
and MCRs is evaluated relative to the permutation
model and CFSs. The percent increase in the
overlap between the ERFSs and MCRs relative to
the permutation model’s expectation (mean ±
SEM, p < 13 104) and CFSs are shown in the left
and right bar graphs, respectively.
(H) ERFSs are enriched for known cancer genes.
The pie chart shows the fraction of putative cancer
genes (Bignell et al., 2010) associated with ERFSs
(p < 6 3 1020). See also Figure S6 and Tables S3
and S4.high resolution copy-number changes detected in biopsies
of patients with diffuse large B cell lymphoma (DLBCL), the
most common type of non-Hodgkins lymphoma (Lenz et al.,
2008). A total of 190 ‘‘minimal common regions’’ (MCRs) were
found among 203 biopsies, carrying a gain or a loss of a chromo-628 Cell 152, 620–632, January 31, 2013 ª2013 Elsevier Inc.somal region ranging in size from 5 kbp
to 21Mbp (Lenz et al., 2008). Mouse
ERFS coordinates were overlaid onto
the human genome using two methods,
yielding 2,205 syntenic regions (Figures
S6B–S6D). Notably, 51.6% of the MCRs
observed in primary DLBCL overlapped
with syntenic ERFS regions (p(permuta-
tion) < 1 3 104, Figure 5F). Moreover,
20.4% of ERFSs overlapped with MCRs,
32% higher than expectation (p(permuta-
tion) < 13 106, Figure 5G). Surprisingly,
ERFS were deleted or amplified in
DLBCL at least 81% more frequently
as compared to CFSs, despite their
cancer-specific propensity for breakage
(Figure 5G). Moreover, our analysis indi-
cated that the DLBCL copy-number alter-
ations exhibited 2-fold higher correlation
with B cell ERFSs compared to deletions
and/or amplifications in T lineage acutelymphoblastic leukemia (Figure S6A) (Zhang et al., 2012a).
Finally, by examining homozygous deletions in cancer genomes
(Bignell et al., 2010), we found that 25 out of 64 genes known to
contribute to oncogenesis coincidewith ERFSs (p(hypergeomet-
ric) < 6 3 1020, Figure 5H; Table S4). Based on these findings,
Figure 6. Model for Recurrent Rearrange-
ments in B Cell Lymphomas
AID is active in G1 (Petersen et al., 2001) and
targets IgH and various oncogenes (e.g., c-myc).
Replication fork collapse at ERFSs in S phase
occurs at preferential sites including various
cancer-associated genes (e.g.,BCL2,BACH2). An
AID-generated break might be passed from G1 to
early S, where it meets an ERFS, which may
eventually result in a translocation (left). Alterna-
tively, an ERFS (bearing unresolved a replication
intermediate of under-replicated DNA)might break
in mitosis and then become permissive to trans-
locate to an AID-induced DSB in the next G1 phase
of the cell cycle (right).we conclude that ERFSs are a significant feature of the muta-
tional landscape of diffuse large B cell lymphomas and poten-
tially other cancers.
DISCUSSION
Replicative Stress at ERFSs Contributes to Genome
Instability in B Cells
Although AID has been implicated in B cell translocations
(Gostissa et al., 2011), very little is known about the mechanisms
of chromosomal breakage at several IgH-partner loci, including
BCL2,BACH2, and FOXP1. Besides programmedDNAdamage,
replication-based mechanisms are a major contributor to chro-
mosomal instability in cancer (Liu et al., 2012). Activated B cells
are among the most rapidly dividing mammalian cells (Zhang
et al., 1988), which potentially exposes them to high endogenous
levels of replicative stress. Here, we have used a genome-wide
approach to identify a subset of early replicating regions in the
B cell genome that are particularly vulnerable to fork collapse
and contribute to rearrangements in B cell malignancies. In our
model, ERFS breaks can occur after the generation of unre-
paired AID-induced breaks in G1, and the two breaks could
recombine during S or G2. Alternatively, ERFS damage might
persist through mitosis resulting in DNA breaks in the subse-
quent G1 phase when AID is predominantly active. In either
case, we suggest that AID-mediated DSBs in G1 (Petersen
et al., 2001), together with replication-stress-induced damage
at recurrent loci, can coordinately drive B cell lymphoma initia-
tion and progression (Figure 6).Cell 152, 620–632ERFS versus CFS
CFSs are considered to be the most
replication-stress-sensitive sites in the
genome (Durkin and Glover, 2007).
Although no single mechanism accounts
for CFS instability, it is hypothesized that
a number of different characteristics
may contribute to their fragility including
co-occurrence with very large genes,
late replication, low density of replication
origins, high A-T content, and sequences
prone to form secondary structures,
histone hypoacetylation, and a con-densed chromatin structure (Helmrich et al., 2011; Jiang et al.,
2009; Letessier et al., 2011; Ozeri-Galai et al., 2011). In stark
contrast to CFSs, our identified ERFSs replicate early; have
an open chromatin configuration; and are origin-, gene-, and
G-C-rich.
Despite these diametrically opposite properties, both CFS
and ERFS fragility are increased by ATR inhibition (Figure 4A),
oncogenic stress (Figure 5B), and deficiencies in HR (Figure 3C)
(Bartek et al., 2007; Durkin and Glover, 2007; Halazonetis et al.,
2008). These conditions decrease the rate of fork progression
but concomitantly increase the density of replication initiating
events (Bester et al., 2011; Daboussi et al., 2008; Dominguez-
Sola et al., 2007; Shechter et al., 2004), which might contribute
to the damage at both CFSs and ERFSs, respectively. The
decrease in fork speed hinders the completion of replication
at CFSs, either because of the scarcity of origins near CFSs
(Letessier et al., 2011), the heterochromatic nature of the regions
that would limit accessibility of DNA replication and/or DSB
repair machineries (Jiang et al., 2009), or because of the interfer-
ence between transcription and replication at very large genes
(Helmrich et al., 2011). Although additional origins are not
activated near CFSs upon replication stress (Letessier et al.,
2011), an increase in origin activity at early replicons might
paradoxically contribute to genome instability at ERFSs. For
example, increasing the replication initiation events near highly
transcribed gene clusters with divergent and/or convergent
gene pairs could increase conflicts between DNA replication
and transcription machineries. The higher density of activated
origins at ERFSs would also be expected to prematurely deplete, January 31, 2013 ª2013 Elsevier Inc. 629
nucleotide pools (Bester et al., 2011), thereby increasing the
probability of subsequent fork stalling and collapse. These two
outcomes of replication stress are likely to be linked because
increased replication initiation and depletion of nucleotide
supplies slows replication (Bester et al., 2011; Jones et al.,
2012), whereas slow fork progression causes activation of
dormant origins (Ge et al., 2007), and both incomplete replication
and increased origin firing are monitored by ATR activity
(Shechter et al., 2004). In conclusion, increased initiating events
at ERFSs and a paucity of replication initiation at CFSs could
both challenge replication fidelity.
ERFSs and Cancer
Oncogenic stress is a major driving force in the early stages of
cancer development (Halazonetis et al., 2008); nevertheless,
the factors that trigger replicative stress in vivo remain unclear.
In the case of B cell lymphomas, oncogenic stress can be initi-
ated by the activity of AID, which by targeting non-Ig genes
such as c-myc (Robbiani et al., 2008), leads to c-myc/IgH trans-
locations and consequent aberrant c-myc expression. This form
of AID-induced oncogenic stress or high levels of proliferative
activity in activated B cells could generate DNA damage at
ERFSs (Figure 6).
Altogether, 103 AID hot spots (Chiarle et al., 2011; Klein et al.,
2011)—including the GIMAP cluster, MHCII locus, and IKZF1—
were also identified as ERFS hot spots in this study (Table S1).
It is possible that the overlap observed between a subset of
off-target AID sites and ERFSs is due to common underlying
features of these loci. For example, AID is recruited to ssDNA
regions (Chaudhuri and Alt, 2004), which are also generated
during replicative stress; AID-dependent DSBs and ERFSs are
also both enriched in repeat elements (Staszewski et al., 2011).
In addition, chromosomal regionswith the highest transcriptional
activity have the highest AID-dependent translocation density
(Chiarle et al., 2011; Klein et al., 2011), and early origins and
translocations frequently reside near transcription start sites
and RNA polymerase-II-binding sites (Chiarle et al., 2011; Klein
et al., 2011). Thus, these euchromatic regions could serve both
as AID targets in G1 and also be susceptible to fork collapse
during early S phase.
A number of different hypotheses have been put forward
about the mechanisms that promote recurrent translocations
in mature B cell lymphomas. These include recurrent genomic
damage by AID, random DNA damage followed by selection,
and a nonrandom 3D organization of the genome (Chiarle
et al., 2011; Hakim et al., 2012; Klein et al., 2011; Zhang
et al., 2012b). To date, replication-stress-induced DNA damage
has been associated with late-replicating CFS. By using an
alternative experimental approach for the discovery of fragile
site expression during early replication, we have identified
a novel source of recurrent AID-independent DNA breaks
that may play a mechanistic role in some of the most common
genome rearrangements during B cell lymphomagenesis.
Because transcriptional activity and replication timing of a
genomic region vary among different cell lineages (Hansen
et al., 2010), different sets of ERFSs might also account for
recurrent chromosomal rearrangements in cancers of distinct
cellular origins.630 Cell 152, 620–632, January 31, 2013 ª2013 Elsevier Inc.EXPERIMENTAL PROCEDURES
Mice
XRCC2/(Frappart et al., 2009), 53BP1/ (Ward et al., 2004), IgkAID
(Robbiani et al., 2009), AID/ (Muramatsu et al., 2000), and SWAP70/
(Borggrefe et al., 2001) mice have been described. SWAP70/ and WT
control mice used in Figure 4D are C57BL/6 background; all other mice are
129/Sv x C57BL/6 background.
ChIP-Seq, Repli-Seq, RNA-Seq, DHS I Mapping, and FISH Analysis
ChIP-seq and RNA-Seq procedures were performed as in Yamane et al.
(2011), Repli-Seq was performed as described in Hansen et al. (2010). DHSI
mapping was performed as described (Sekimata et al., 2009), and fluores-
cence in situ hybridization (FISH) analysis is described in Calle´n et al. (2007).
For detailed methods, see Extended Experimental Procedures.
BACs
Individual BACs to ERFSs were identified using NCBI clone finder and
purchased from BACPAC. For complete list of BAC probes used in FISH
experiments see Extended Experimental Procedures.
Retroviral Infection
Cells were infected with pMX-c-Myc-IRES-GFP or empty vector and GFP-
positive cells were sorted as described (Robbiani et al., 2008).
Statistical and Computational Analyses
Detailed description is available in Extended Experimental Procedures.
ACCESSION NUMBERS
The ChIP-seq and RNA-seq data are deposited in GEO under accession
number GSE43504.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and four tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2013.01.006.
ACKNOWLEDGMENTS
We thank Rolf Jessberger and Alessandra Pernis for SWAP70/ mice, Mila
Jankovic for pMX-c-Myc-IRES-GFP, Jean Gautier, Mirit Aladjem, and Toren
Finkel for discussions and Lars Grontved for help with DHS mapping. This
work was supported by the Intramural Research Program of the NIH, the
National Cancer Institute, and the Center for Cancer Research, and by
a Department of Defense grant to A.N. (BC102335). This study utilized the
high-performance computational capabilities of the Biowulf Linux cluster at
the NIH.
Received: November 9, 2012
Revised: December 10, 2012
Accepted: January 2, 2013
Published: January 24, 2013
REFERENCES
Bartek, J., Bartkova, J., and Lukas, J. (2007). DNA damage signalling guards
against activated oncogenes and tumour progression. Oncogene 26, 7773–
7779.
Bester, A.C., Roniger, M., Oren, Y.S., Im, M.M., Sarni, D., Chaoat, M., Bensi-
mon, A., Zamir, G., Shewach, D.S., and Kerem, B. (2011). Nucleotide defi-
ciency promotes genomic instability in early stages of cancer development.
Cell 145, 435–446.
Bignell, G.R., Greenman, C.D., Davies, H., Butler, A.P., Edkins, S., Andrews,
J.M., Buck, G., Chen, L., Beare, D., Latimer, C., et al. (2010). Signatures of
mutation and selection in the cancer genome. Nature 463, 893–898.
Borggrefe, T., Keshavarzi, S., Gross, B., Wabl, M., and Jessberger, R. (2001).
Impaired IgE response in SWAP-70-deficient mice. Eur. J. Immunol. 31, 2467–
2475.
Bothmer, A., Robbiani, D.F., Feldhahn, N., Gazumyan, A., Nussenzweig, A.,
andNussenzweig,M.C. (2010). 53BP1 regulates DNA resection and the choice
between classical and alternative end joining during class switch recombina-
tion. J. Exp. Med. 207, 855–865.
Bunting, S.F., Calle´n, E., Kozak, M.L., Kim, J.M., Wong, N., Lo´pez-Contreras,
A.J., Ludwig, T., Baer, R., Faryabi, R.B., Malhowski, A., et al. (2012). Mol. Cell
46, 125–135.
Bunting, S.F., Calle´n, E., Wong, N., Chen, H.T., Polato, F., Gunn, A., Bothmer,
A., Feldhahn, N., Fernandez-Capetillo, O., Cao, L., et al. (2010). 53BP1 inhibits
homologous recombination in Brca1-deficient cells by blocking resection of
DNA breaks. Cell 141, 243–254.
Calle´n, E., Jankovic, M., Difilippantonio, S., Daniel, J.A., Chen, H.T., Celeste,
A., Pellegrini, M., McBride, K., Wangsa, D., Bredemeyer, A.L., et al. (2007).
ATM prevents the persistence and propagation of chromosome breaks in
lymphocytes. Cell 130, 63–75.
Cha, R.S., and Kleckner, N. (2002). ATR homolog Mec1 promotes fork
progression, thus averting breaks in replication slow zones. Science 297,
602–606.
Chaudhuri, J., and Alt, F.W. (2004). Class-switch recombination: interplay
of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 4,
541–552.
Chen, H.T., Bhandoola, A., Difilippantonio, M.J., Zhu, J., Brown, M.J., Tai, X.,
Rogakou, E.P., Brotz, T.M., Bonner, W.M., Ried, T., and Nussenzweig, A.
(2000). Response to RAG-mediated VDJ cleavage by NBS1 and gamma-
H2AX. Science 290, 1962–1965.
Chiarle, R., Zhang, Y., Frock, R.L., Lewis, S.M., Molinie, B., Ho, Y.J., Myers,
D.R., Choi, V.W., Compagno, M., Malkin, D.J., et al. (2011). Genome-wide
translocation sequencing reveals mechanisms of chromosome breaks and
rearrangements in B cells. Cell 147, 107–119.
Cimprich, K.A., and Cortez, D. (2008). ATR: an essential regulator of genome
integrity. Nat. Rev. Mol. Cell Biol. 9, 616–627.
Costa, S., and Blow, J.J. (2007). The elusive determinants of replication
origins. EMBO Rep. 8, 332–334.
Daboussi, F., Courbet, S., Benhamou, S., Kannouche, P., Zdzienicka, M.Z.,
Debatisse, M., and Lopez, B.S. (2008). A homologous recombination defect
affects replication-fork progression in mammalian cells. J. Cell Sci. 121,
162–166.
Debatisse, M., Le Tallec, B., Letessier, A., Dutrillaux, B., and Brison, O. (2012).
Common fragile sites: mechanisms of instability revisited. Trends Genet. 28,
22–32.
Dominguez-Sola, D., Ying, C.Y., Grandori, C., Ruggiero, L., Chen, B., Li, M.,
Galloway, D.A., Gu, W., Gautier, J., and Dalla-Favera, R. (2007). Non-tran-
scriptional control of DNA replication by c-Myc. Nature 448, 445–451.
Durkin, S.G., and Glover, T.W. (2007). Chromosome fragile sites. Annu. Rev.
Genet. 41, 169–192.
Feng, W., Collingwood, D., Boeck, M.E., Fox, L.A., Alvino, G.M., Fangman,
W.L., Raghuraman, M.K., and Brewer, B.J. (2006). Genomic mapping of
single-stranded DNA in hydroxyurea-challenged yeasts identifies origins of
replication. Nat. Cell Biol. 8, 148–155.
Frappart, P.O., Lee, Y., Russell, H.R., Chalhoub, N., Wang, Y.D., Orii, K.E.,
Zhao, J., Kondo, N., Baker, S.J., and McKinnon, P.J. (2009). Recurrent
genomic alterations characterize medulloblastoma arising from DNA double-
strand break repair deficiency. Proc. Natl. Acad. Sci. USA 106, 1880–1885.
Ge, X.Q., Jackson, D.A., and Blow, J.J. (2007). Dormant origins licensed by
excess Mcm2-7 are required for human cells to survive replicative stress.
Genes Dev. 21, 3331–3341.Gostissa, M., Alt, F.W., and Chiarle, R. (2011). Mechanisms that promote and
suppress chromosomal translocations in lymphocytes. Annu. Rev. Immunol.
29, 319–350.
Hakim, O., Resch, W., Yamane, A., Klein, I., Kieffer-Kwon, K.R., Jankovic, M.,
Oliveira, T., Bothmer, A., Voss, T.C., Ansarah-Sobrinho, C., et al. (2012). DNA
damage defines sites of recurrent chromosomal translocations in B lympho-
cytes. Nature 484, 69–74.
Halazonetis, T.D., Gorgoulis, V.G., and Bartek, J. (2008). An oncogene-
induced DNA damage model for cancer development. Science 319, 1352–
1355.
Hansen, R.S., Thomas, S., Sandstrom, R., Canfield, T.K., Thurman, R.E.,
Weaver, M., Dorschner, M.O., Gartler, S.M., and Stamatoyannopoulos, J.A.
(2010). Sequencing newly replicated DNA reveals widespread plasticity in
human replication timing. Proc. Natl. Acad. Sci. USA 107, 139–144.
Hashash, N., Johnson, A.L., and Cha, R.S. (2011). Regulation of fragile sites
expression in budding yeast by MEC1, RRM3 and hydroxyurea. J. Cell Sci.
124, 181–185.
Helmrich, A., Stout-Weider, K., Hermann, K., Schrock, E., and Heiden, T.
(2006). Common fragile sites are conserved features of human and mouse
chromosomes and relate to large active genes. Genome Res. 16, 1222–1230.
Helmrich, A., Ballarino, M., and Tora, L. (2011). Collisions between replication
and transcription complexes cause common fragile site instability at the
longest human genes. Mol. Cell 44, 966–977.
Jiang, Y., Lucas, I., Young, D.J., Davis, E.M., Karrison, T., Rest, J.S., and Le
Beau, M.M. (2009). Common fragile sites are characterized by histone hypoa-
cetylation. Hum. Mol. Genet. 18, 4501–4512.
Jones, R.M., Mortusewicz, O., Afzal, I., Lorvellec, M., Garcı´a, P., Helleday, T.,
and Petermann, E. (2012). Increased replication initiation and conflicts with
transcription underlie Cyclin E-induced replication stress. Oncogene.
Published online September 3, 2012.
Kato, L., Begum, N.A., Burroughs, A.M., Doi, T., Kawai, J., Daub, C.O., Kawa-
guchi, T., Matsuda, F., Hayashizaki, Y., and Honjo, T. (2012). Nonimmunoglo-
bulin target loci of activation-induced cytidine deaminase (AID) share unique
features with immunoglobulin genes. Proc. Natl. Acad. Sci. USA 109, 2479–
2484.
Klein, I.A., Resch, W., Jankovic, M., Oliveira, T., Yamane, A., Nakahashi, H.,
Di Virgilio, M., Bothmer, A., Nussenzweig, A., Robbiani, D.F., et al. (2011).
Translocation-capture sequencing reveals the extent and nature of chromo-
somal rearrangements in B lymphocytes. Cell 147, 95–106.
Kobayashi, S., Taki, T., Chinen, Y., Tsutsumi, Y., Ohshiro, M., Kobayashi, T.,
Matsumoto, Y., Kuroda, J., Horiike, S., Nishida, K., and Taniwaki, M. (2011).
Identification of IGHCd-BACH2 fusion transcripts resulting from cryptic
chromosomal rearrangements of 14q32 with 6q15 in aggressive B-cell
lymphoma/leukemia. Genes Chromosomes Cancer 50, 207–216.
Lenz, G., Wright, G.W., Emre, N.C., Kohlhammer, H., Dave, S.S., Davis, R.E.,
Carty, S., Lam, L.T., Shaffer, A.L., Xiao, W., et al. (2008). Molecular subtypes of
diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc. Natl.
Acad. Sci. USA 105, 13520–13525.
Letessier, A., Millot, G.A., Koundrioukoff, S., Lachage`s, A.M., Vogt, N.,
Hansen, R.S., Malfoy, B., Brison, O., and Debatisse, M. (2011). Cell-type-
specific replication initiation programs set fragility of the FRA3B fragile site.
Nature 470, 120–123.
Liu, M., Duke, J.L., Richter, D.J., Vinuesa, C.G., Goodnow, C.C., Kleinstein,
S.H., and Schatz, D.G. (2008). Two levels of protection for the B cell genome
during somatic hypermutation. Nature 451, 841–845.
Liu, P., Carvalho, C.M., Hastings, P.J., and Lupski, J.R. (2012). Mechanisms
for recurrent and complex human genomic rearrangements. Curr. Opin.
Genet. Dev. 22, 211–220.
MacAlpine, D.M., Rodrı´guez, H.K., and Bell, S.P. (2004). Coordination of repli-
cation and transcription along a Drosophila chromosome. Genes Dev. 18,
3094–3105.
Mirkin, E.V., and Mirkin, S.M. (2007). Replication fork stalling at natural imped-
iments. Microbiol. Mol. Biol. Rev. 71, 13–35.Cell 152, 620–632, January 31, 2013 ª2013 Elsevier Inc. 631
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., and
Honjo, T. (2000). Class switch recombination and hypermutation require acti-
vation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell
102, 553–563.
Ozeri-Galai, E., Lebofsky, R., Rahat, A., Bester, A.C., Bensimon, A., and
Kerem, B. (2011). Failure of origin activation in response to fork stalling leads
to chromosomal instability at fragile sites. Mol. Cell 43, 122–131.
Petermann, E., Orta, M.L., Issaeva, N., Schultz, N., and Helleday, T. (2010).
Hydroxyurea-stalled replication forks become progressively inactivated and
require two different RAD51-mediated pathways for restart and repair. Mol.
Cell 37, 492–502.
Petersen, S., Casellas, R., Reina-San-Martin, B., Chen, H.T., Difilippantonio,
M.J., Wilson, P.C., Hanitsch, L., Celeste, A., Muramatsu, M., Pilch, D.R.,
et al. (2001). AID is required to initiate Nbs1/gamma-H2AX focus formation
and mutations at sites of class switching. Nature 414, 660–665.
Raveendranathan, M., Chattopadhyay, S., Bolon, Y.T., Haworth, J., Clarke,
D.J., and Bielinsky, A.K. (2006). Genome-wide replication profiles of S-phase
checkpoint mutants reveal fragile sites in yeast. EMBO J. 25, 3627–3639.
Robbiani, D.F., Bothmer, A., Callen, E., Reina-San-Martin, B., Dorsett, Y.,
Difilippantonio, S., Bolland, D.J., Chen, H.T., Corcoran, A.E., Nussenzweig,
A., and Nussenzweig, M.C. (2008). AID is required for the chromosomal breaks
in c-myc that lead to c-myc/IgH translocations. Cell 135, 1028–1038.
Robbiani, D.F., Bunting, S., Feldhahn, N., Bothmer, A., Camps, J., Deroubaix,
S., McBride, K.M., Klein, I.A., Stone, G., Eisenreich, T.R., et al. (2009).
AID produces DNA double-strand breaks in non-Ig genes and mature B cell
lymphomas with reciprocal chromosome translocations. Mol. Cell 36,
631–641.
Schlacher, K., Wu, H., and Jasin, M. (2012). A distinct replication fork protec-
tion pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/
2. Cancer Cell 22, 106–116.
Sekimata, M., Pe´rez-Melgosa, M., Miller, S.A., Weinmann, A.S., Sabo, P.J.,
Sandstrom, R., Dorschner, M.O., Stamatoyannopoulos, J.A., and Wilson,
C.B. (2009). CCCTC-binding factor and the transcription factor T-bet orches-
trate T helper 1 cell-specific structure and function at the interferon-gamma
locus. Immunity 31, 551–564.
Shechter, D., Costanzo, V., and Gautier, J. (2004). ATR and ATM regulate the
timing of DNA replication origin firing. Nat. Cell Biol. 6, 648–655.
Sonoda, E., Sasaki, M.S., Buerstedde, J.M., Bezzubova, O., Shinohara, A.,
Ogawa, H., Takata, M., Yamaguchi-Iwai, Y., and Takeda, S. (1998). Rad51-
deficient vertebrate cells accumulate chromosomal breaks prior to cell death.
EMBO J. 17, 598–608.
Stamatoyannopoulos, J.A., Snyder, M., Hardison, R., Ren, B., Gingeras, T.,
Gilbert, D.M., Groudine, M., Bender, M., Kaul, R., Canfield, T., et al.; Mouse
ENCODE Consortium. (2012). An encyclopedia of mouse DNA elements
(Mouse ENCODE). Genome Biol. 13, 418.632 Cell 152, 620–632, January 31, 2013 ª2013 Elsevier Inc.Staszewski, O., Baker, R.E., Ucher, A.J., Martier, R., Stavnezer, J., and
Guikema, J.E. (2011). Activation-induced cytidine deaminase induces repro-
ducible DNA breaks at many non-Ig Loci in activated B cells. Mol. Cell 41,
232–242.
Stephan, A.K., Kliszczak, M., and Morrison, C.G. (2011). The Nse2/Mms21
SUMO ligase of the Smc5/6 complex in the maintenance of genome stability.
FEBS Lett. 585, 2907–2913.
Tanaka, T., and Nasmyth, K. (1998). Association of RPA with chromosomal
replication origins requires an Mcm protein, and is regulated by Rad53, and
cyclin- and Dbf4-dependent kinases. EMBO J. 17, 5182–5191.
Toledo, L.I., Murga, M., Zur, R., Soria, R., Rodriguez, A., Martinez, S., Oyarza-
bal, J., Pastor, J., Bischoff, J.R., and Fernandez-Capetillo, O. (2011). A cell-
based screen identifies ATR inhibitors with synthetic lethal properties for
cancer-associated mutations. Nat. Struct. Mol. Biol. 18, 721–727.
Tsai, A.G., Lu, H., Raghavan, S.C., Muschen, M., Hsieh, C.L., and Lieber, M.R.
(2008). Human chromosomal translocations at CpG sites and a theoretical
basis for their lineage and stage specificity. Cell 135, 1130–1142.
Ward, I.M., and Chen, J. (2001). Histone H2AX is phosphorylated in an ATR-
dependent manner in response to replicational stress. J. Biol. Chem. 276,
47759–47762.
Ward, I.M., Reina-San-Martin, B., Olaru, A., Minn, K., Tamada, K., Lau, J.S.,
Cascalho, M., Chen, L., Nussenzweig, A., Livak, F., et al. (2004). 53BP1 is
required for class switch recombination. J. Cell Biol. 165, 459–464.
Yamane, A., Resch, W., Kuo, N., Kuchen, S., Li, Z., Sun, H.W., Robbiani, D.F.,
McBride, K., Nussenzweig, M.C., and Casellas, R. (2011). Deep-sequencing
identification of the genomic targets of the cytidine deaminase AID and its
cofactor RPA in B lymphocytes. Nat. Immunol. 12, 62–69.
Yamane, A., Robbiani, D.F., Resch, W., Bothmer, A., Nakahashi, H., Oliveira,
T., Rommel, P.C., Brown, E.J., Nussenzweig, A., Nussenzweig, M.C., et al.
(2013). RPA accumulation during class switch recombination represents
50-30 DNA end resection during S-G2/M phase of the cell cycle. Cell Rep.
Published January 02, 2013. http://dx.doi.org/10.1016/j.celrep.2012.12.006.
Zhang, J., MacLennan, I.C., Liu, Y.J., and Lane, P.J. (1988). Is rapid prolifera-
tion in B centroblasts linked to somatic mutation in memory B cell clones?
Immunol. Lett. 18, 297–299.
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S.L., Payne-Turner, D.,
Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012a). The genetic basis
of early T-cell precursor acute lymphoblastic leukaemia. Nature 481, 157–163.
Zhang, Y., McCord, R.P., Ho, Y.J., Lajoie, B.R., Hildebrand, D.G., Simon, A.C.,
Becker, M.S., Alt, F.W., and Dekker, J. (2012b). Spatial organization of the
mouse genome and its role in recurrent chromosomal translocations. Cell
148, 908–921.
